NTLA-2001
Intellia Therapeutics,medtronic
['apollo', 'crispr']
comparing the study findings to those of #apollo-b for the #sirna therapy patisiran , apollo-b reported a mean 87% reduction in #ttr so, so the effect of gene editing matches and actually exceeds the effect of #patisiran in #crispr/cas-9 gene editing #aha22 
Cardiologist FACC, FESC | Physician-scientist @UVMHealth | Nature Lover?? | #HeartFailure???????| #HFA & #EACVI Committee @escardio | Content Catalyst in @TCTMD